BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11853610)

  • 1. [Point mutations of N-ras oncogene and abnormal expression of rasp21, p53 proteins in orbital rhabdomyosarcoma].
    Zhang H; Song G; Zhang S; Chang J; Zhang W; Yu H
    Zhonghua Yan Ke Za Zhi; 2000 Jul; 36(4):267-9, 16. PubMed ID: 11853610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orbital rhabdomyosarcoma: relationship between DNA ploidy, p53, bcl-2, MDR-1 and Ki67 (MIB1) expression and clinical behavior.
    Staibano S; Franco R; Tranfa F; Mezza E; Lo Muzio L; Strianese D; Errico ME; Bufo P; Ferrara G; Somma P; Mansueto G; Greco I; Fiorillo A; Bonavolontà G; De Rosa G
    Anticancer Res; 2004; 24(1):249-57. PubMed ID: 15015604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant point mutation of tumor suppressor gene p53 and oncogene c-N-ras in malignant neuroendocrine pancreatic tumor.
    Hrasćan R; Pavelić K; Pavicić D; Krizanac S; Stajcer-Sittić V; Pecur L; Spaventi S; Klimpfinger M; Pavelić J
    Anticancer Res; 1996; 16(6B):3761-6. PubMed ID: 9042254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and alteration of ras and p53 proteins in patients with lung carcinoma accompanied by idiopathic pulmonary fibrosis.
    Takahashi T; Munakata M; Ohtsuka Y; Nisihara H; Nasuhara Y; Kamachi-Satoh A; Dosaka-Akita H; Homma Y; Kawakami Y
    Cancer; 2002 Aug; 95(3):624-33. PubMed ID: 12209756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of c-ras gene mutation and expression of p21 protein in dysplasias and carcinomas complicating ulcerative colitis.
    Tsuda T; Mochizuki M; Wakasa H
    J Gastroenterol; 1995 Nov; 30 Suppl 8():30-2. PubMed ID: 8563883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of point mutations in N-ras and K-ras genes of human embryonal rhabdomyosarcomas using oligonucleotide probes and the polymerase chain reaction.
    Stratton MR; Fisher C; Gusterson BA; Cooper CS
    Cancer Res; 1989 Nov; 49(22):6324-7. PubMed ID: 2680062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of microsatellite instability, K-ras gene mutation and p53 protein overexpression in intrahepatic cholangiocarcinoma.
    Isa T; Tomita S; Nakachi A; Miyazato H; Shimoji H; Kusano T; Muto Y; Furukawa M
    Hepatogastroenterology; 2002; 49(45):604-8. PubMed ID: 12063950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular oncological study on DNA ploidy, Ki-ras point mutation, and p21 expression in colorectal cancer].
    Yamazaki K; Sato K; Hirata S; Ikeda K; Kubo Y; Matsui H; Ogawa K
    Nihon Geka Gakkai Zasshi; 1994 Apr; 95(4):242-7. PubMed ID: 8196591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunomorphology in the diagnosis of orbital rhabdomyosarcoma].
    Andreeva LD; Khoroshilova-Maslova IP
    Vestn Oftalmol; 2009; 125(2):10-4. PubMed ID: 19517823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 expression and p21 expression are mutually exclusive in esophageal squamous cell carcinoma.
    Hamada M; Naomoto Y; Shirakawa Y; Yamatsuji T; Noma K; Motoki T; Nobuhisa T; Okawa T; Haisa M; Gunduz M; Matsuoka J; Tanaka N
    Oncol Rep; 2004 Jan; 11(1):57-63. PubMed ID: 14654903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microvessel density, cyclo-oxygenase 2 expression, K-ras mutation and p53 overexpression in colonic cancer.
    Liang JT; Huang KC; Jeng YM; Lee PH; Lai HS; Hsu HC
    Br J Surg; 2004 Mar; 91(3):355-61. PubMed ID: 14991639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ki-ras point mutation and p53 expression in human pancreatic cancer: a comparative study among Chinese, Japanese, and Western patients.
    Dong M; Nio Y; Tamura K; Song MM; Guo KJ; Guo RX; Dong YT
    Cancer Epidemiol Biomarkers Prev; 2000 Mar; 9(3):279-84. PubMed ID: 10750666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of K-ras point mutation, telomerase activity, and p53 overexpression in pancreatic tumours.
    Uemura K; Hiyama E; Murakami Y; Kanehiro T; Ohge H; Sueda T; Yokoyama T
    Oncol Rep; 2003; 10(2):277-83. PubMed ID: 12579258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of p53 gene mutations in the supernatant of bile for diagnosis of biliary tract carcinoma: comparison with K- ras mutation.
    Wang Y; Yamaguchi Y; Watanabe H; Ohtsubo K; Wakabayashi T; Sawabu N
    J Gastroenterol; 2002; 37(10):831-9. PubMed ID: 12424567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced ING1b gene expression plays an important role in carcinogenesis of non-small cell lung cancer patients.
    Kameyama K; Huang CL; Liu D; Masuya D; Nakashima T; Sumitomo S; Takami Y; Kinoshita M; Yokomise H
    Clin Cancer Res; 2003 Oct; 9(13):4926-34. PubMed ID: 14581367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ki-ras mutations in codon 12 and p53 mutations (biomarkers) and cytology in bile in patients with hepatobiliary-pancreatic carcinoma.
    Yamaguchi K; Nakano K; Nagai E; Chijiiwa K; Kinoshita M; Ohta M; Tanaka M
    Hepatogastroenterology; 2005; 52(63):713-8. PubMed ID: 15966189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Protein expression of p53, bcl-2, and bax in adenoid cystic carcinoma of lacrimal gland].
    You JQ; Wang P
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1978-82. PubMed ID: 19062739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Quantitative studies of oncogene ras P21 and P53 gene protein expression in the benign and malignant pleomorphic adenomas of salivary gland].
    Wang J; Dong F; Wang X
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1997 Jul; 32(4):208-11. PubMed ID: 10680505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The relationship between expression of oncogene proteins and HBeAg in chronic hepatitis B virus infection].
    Hong F; Zhang C; Zhao H
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Sep; 12(3):249-50. PubMed ID: 12526327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infrequent p53 gene mutations and lack of p53 protein expression in clear cell sarcoma of the kidney: immunohistochemical study and mutation analysis of p53 in renal tumors of unfavorable prognosis.
    Hsueh C; Wang H; Gonzalez-Crussi F; Lin JN; Hung IJ; Yang CP; Jiang TH
    Mod Pathol; 2002 Jun; 15(6):606-10. PubMed ID: 12065773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.